Cargando…

Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis

Multiorgan fibrosis in systemic sclerosis (SSc) accounts for substantial mortality and lacks effective therapies. Lying at the crossroad of TGF-β and TLR signaling, TGF-β–activated kinase 1 (TAK1) might have a pathogenic role in SSc. We therefore sought to evaluate the TAK1 signaling axis in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bale, Swarna, Verma, Priyanka, Yalavarthi, Bharath, Scarneo, Scott Arthur, Hughes, Philip, Amin, M. Asif, Tsou, Pei-Suen, Khanna, Dinesh, Haystead, Timothy A.J., Bhattacharyya, Swati, Varga, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443806/ https://www.ncbi.nlm.nih.gov/pubmed/37306632 http://dx.doi.org/10.1172/jci.insight.165358

Ejemplares similares

Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis
por: Wang, Wenxia, et al.
Publicado: (2022)

TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades
por: Scarneo, Scott A., et al.
Publicado: (2020)

Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis
por: Freeze, Robert, et al.
Publicado: (2023)

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice
por: Scarneo, Scott A., et al.
Publicado: (2019)

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion
por: Scarneo, Scott A., et al.
Publicado: (2018)

TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
por: Totzke, Juliane, et al.
Publicado: (2020)

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2018)

Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
por: Kim, Seok-Jo, et al.
Publicado: (2022)

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
por: Wang, Wenxia, et al.
Publicado: (2022)

Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
por: Wang, Wenxia, et al.
Publicado: (2023)

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
por: Tsou, Pei-Suen, et al.
Publicado: (2019)

Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186
por: Dettling, Danielle E, et al.
Publicado: (2022)

PLG nanoparticles target fibroblasts and MARCO(+) monocytes to reverse multiorgan fibrosis
por: Xu, Dan, et al.
Publicado: (2022)

TAK1ng control: TAK1 restrains NLRP3 activation
por: Mangan, Matthew Stephen, et al.
Publicado: (2018)

Activation of the thromboxane A2 receptor by 8-isoprostane inhibits the pro-angiogenic effect of vascular endothelial growth factor in scleroderma
por: Tsou, Pei-Suen, et al.
Publicado: (2015)

Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts
por: Tsou, Pei-Suen, et al.
Publicado: (2014)

Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis
por: Varga, Zsófia, et al.
Publicado: (2020)

Multifaceted Roles of TAK1 Signaling in Cancer
por: Mukhopadhyay, Himadri, et al.
Publicado: (2019)

An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines
por: Bale, Swarna, et al.
Publicado: (2018)

TAK1 is an essential regulator of BMP signalling in cartilage
por: Shim, Jae-Hyuck, et al.
Publicado: (2009)

Post-Translational Modifications of the TAK1-TAB Complex
por: Hirata, Yusuke, et al.
Publicado: (2017)

Is TAK1 a Direct Upstream Kinase of AMPK?
por: Neumann, Dietbert
Publicado: (2018)

TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
por: Campolo, Michela, et al.
Publicado: (2020)

Knee Meniscus Posterior Root Repair with FiberTak
por: Mesquita Queirós, Carlos, et al.
Publicado: (2022)

Molecular mechanism of the wake-promoting agent TAK-925
por: Yin, Jie, et al.
Publicado: (2022)

Inflammatory Mediator TAK1 Regulates Hair Follicle Morphogenesis and Anagen Induction Shown by Using Keratinocyte-Specific TAK1-Deficient Mice
por: Sayama, Koji, et al.
Publicado: (2010)

FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway
por: Chen, Xi, et al.
Publicado: (2022)

Senescent Cells Accumulate in Systemic Sclerosis Skin
por: Shi, Bo, et al.
Publicado: (2023)

Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
por: Geng, Jiefei, et al.
Publicado: (2017)

Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis
por: Wei, Jun, et al.
Publicado: (2012)

TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice
por: Tang, Minghui, et al.
Publicado: (2008)

TAK1 in brain endothelial cells mediates fever and lethargy
por: Ridder, Dirk A., et al.
Publicado: (2011)

Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins
por: Mihaly, September R., et al.
Publicado: (2014)

ACCESSIBILITY OF HEALTH CARE SERVICE IN THASONGYANG, TAK PROVINCE, THAILAND
por: YINGTAWEESAK, TAWATCHAI, et al.
Publicado: (2013)

Brain endothelial TAK1 and NEMO safeguard the neurovascular unit
por: Ridder, Dirk A., et al.
Publicado: (2015)

TAK1 regulates hepatic lipid homeostasis through SREBP
por: Morioka, Sho, et al.
Publicado: (2016)

TAK1 regulates resident macrophages by protecting lysosomal integrity
por: Sakamachi, Yosuke, et al.
Publicado: (2017)

Pharmacological approaches to the prevention of type 2 diabetes mellitus
por: Majety, Priyanka, et al.
Publicado: (2023)

A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers
por: Nagaraja, Vivek, et al.
Publicado: (2019)

TensorFlow for deep learning: from linear regression to reinforcement learning
por: Ramsundar, Bharath, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_550ue952o7go7l20f4kvp4ee64